Swirsky Douglas J - Insider Stock Trading - OpenInsider

CIK: 1375884 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850

10 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	7	-7	-8	-11	-27	-27	-50	-22
P	%wins				43	57	43	29	29	0	33

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/14/21 16:00	9/14/21	CLRB	Cellectar Biosciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	NJ	D		P	26	1.04	0	25	New	25	D
1/30/19 07:32	1/29/19	RNN	Rexahn Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	DO	P,CEO	P	32	0.6344	0	50	New	50	D
6/20/17 16:33	6/16/17	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	DO	P,CEO	M.d	140	5.60	0	25		0	D
9/16/16 15:09	9/16/16	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	DO	P,CEO	P	5	0.5000	0	10	4	253	D	-76	-78	-25	-11	-2	-13	-2	0	-7	-11	-31	-46	20
12/15/15 09:33	12/14/15	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	DO	P,CEO	P	10	2.00	0	5	2	243	D	-16	4	-7	-20	2	7	-19	-4	-1	2	-71	-63	-69	-84
8/7/15 14:12	12/15/14	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	DO	P,CEO	P.a	10	1.90	0	6	2	238	D	385	-1	-44	-5	10	-7	-11	-6	1	4	13	-11	-78	-74
8/16/11 10:47	8/12/11	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	O	SVP,CFO	P	57	2.30	0	25	421	31	D	-69	-55	-53	-46	-25	-20	2	15	2	16	26	17	8	-22
11/19/08 11:23	11/19/08	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	O	CFO	P	7	0.7095	0	10	100	20	D	-24	-44	-32	-22	6	21	19	-4	-47	-67	-51	-67	-41	-25
11/15/07 14:17	11/15/07	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	O	CFO	P	12	2.30	0	5	100	10	D	39	52	-48	0	-3	-9	-5	-1	-1	-7	-35	-39	-22	-46
3/19/07 14:52	3/19/07	GNVC	Genvec Inc	DE	Health	Drug	Pharmaceutical Preparations	Swirsky Douglas J	MD	O	CFO	P	13	2.52	0	5	New	5	D	27	12	124	59	-21	-25	-10	-10	2	8	70	17	-6	-47

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact